Metronidazole resistance reduces efficacy of triple therapy and leads to secondary clarithromycin resistance

Digestive Diseases and Sciences

Volumn 42, Issue 10, 1997, Pages 2111-2115

  Buckley, Martin J M ^b   Xia, Hua Xiang ^b   Hyde, Denise M ^b   Keane, Conor T ^b   O'Morain, Colm A ^a  

^a ADELAIDE AND MEATH HOSPITAL   (Ireland)

^b NONE

Author keywords

Antimicrobial resistance; Clarithromycin; Helicobacter pylori; Metronidazole; Proton pump inhibitor

Indexed keywords

CLARITHROMYCIN; METRONIDAZOLE; OMEPRAZOLE; OXOID; UNCLASSIFIED DRUG;

ANTIBIOTIC RESISTANCE; ARTICLE; DRUG EFFICACY; DUODENUM ULCER; HELICOBACTER PYLORI; PREVALENCE; PRIORITY JOURNAL; TREATMENT FAILURE;

EID: 0030831362     PISSN: 01632116     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1018882804607     Document Type: Article

References (46)

1. Coghlan JG, Gilligan D. Humphries H, McKenna D, Dooley C. Sweeney E, Keane C, O'Morain C: Campylabacter pylori and recurrence of duodenal ulcers-a 12 month follow-up study. Lancet 2:109-111, 1987
2. Marshall BJ, Goodwill CS, Warren JR, Murray R, Blincow ED, Blackbourn SJ, Phillips M2, Walers TE, Sanderson CR: A prospective double-blind trial of duodenal ulcer relapse after eradication of Campylobacter pylori. Lancet 2:1437-1442, 1988
3. Logan RIM I, Gummett PA, Misiewicz JJ, Karim QM, Walker MM, Baron JH: One week's anti-Helicobacter pylori treatment for duodenal ulcer. Gut 35:15-18, 1994
4. Hosking SW, Ling TKW, Chung SCS, et al: Duodenal ulcer healing by eradication of Helicobacter pylori without anti-acid treatment. Lancet 343:508-510, 1994
5. Penston JG: Review article: Helicobacter priori eradicationunderstandable caution but no excuse for inertia. Aliment Pharmacol Ther 8:364-389, 1994
6. O'Riordan T, Mathai E, Tobin E, McKenna D, Keane C, Sweeney E, O'Morain C: Adjuvant antibiotic therapy in duodenal ulcers treated with colloidal bismuth subcitrate. Gut 31:999-1002, 1990
7. O'Connor HJ: Eradication of Helicobacter pylori: Therapies and clinical implications. Postgrad Med J 102:493-496, 1992
8. Graham DY, Lew GM, Malaty HM, Evans DG, Evans DG Jr. Klein PD, Alpert LC, Genta RM: Factors influencing the eradication of Helicobacter pylori with triple therapy. Gastroenterology 102:493-496, 1992
9. Noach LA, Lagenberg WL, Bertola MA, Dankert J, Tytgat GNJ: Impact of metronidazole resistance on the eradication of Helicobacter pylori. Scand J Infect Dis 26:321-327, 1994
10. Bell GD, Powell K, Burridge SM, Pallecaros A, Jones PH, Gant PW, Marrison G, Trowell JE: Experience with "triple" anti-Helicobacter pylori eradication therapy: Side-effects and importance of testing pre-treatment bacterial isolates for metronidazole resistance. Aliment Pharmacol Ther 6:427-435, 1992
11. Noach LA, Bertola MA, Schwartz MP, Rauws EAJ, Tytgat GNJ: Treatment of Helicobacter pylori infection: An evaluation of various therapeutic trials. Eur J Gastroenterol Hepatol 6:585-591, 1994
12. Xia HX, Daw MA, Beattie S, Keane CT. O'Morain CA: The influence of metronidazole resistance on triple therapy for Helicobacter pylori-associated duodenal ulcer. Am J Gastronenterol 102:A947, 1992 (abstract)
13. Glupeznski Y, Burette A: Drug therapy for Helicobacter pylori infection: Problems and pitfalls. Am J Gastroenterol 85:1545-1551, 1990
14. Megraud E, Boyanova L, Lamouliatte H: Activity of lansoprazole against H. pylori. Lancet 337(1): 1486, 1991 (letter)
15. Unge P, Gad A, Gnarpe H, Olsson J: Does omeprazole improve antimicrobial therapy directed towards gastric Campylobacter pylori in patients with antral gastritis. Scand J Gastroenterol 24(suppl 167):49-54, 1989
16. Louw JA, Zak J, Jaskicwicz K, Lucke W, LeRoux E, Winter T, Lastouica A, Marks IN: Omeprazole may clear but does not eradicate H. pylori. Eur J Gastroenterol Hepatol 4:481-485, 1992
17. McNulty CAM. Dent JC, Ford GA, Wilkinson SP: Inhibitory antimicrobial concentrations against H. pylori in gastric mucosa. J Antimicrob Chemother 22:727-738, 1988
18. Peterson WL, Graham DY, Marshall B, Blaser MJ, Genta RM, Klein PD, Stratum CW, Drnee J, Prokocimer P, Siepman N: Clarithromycin as monotherapy for eradication of Helicobacter pylori: A randomised double-blind trial. Am J Gastroenterol 88:1860-1864, 1993
19. Hardy DJ, Hanson CW, Hensey DM, Beyer JM, Fernandes PB: Susceptibility of Campylobacter pylori to macrolides and flouroquinolones. J Antimicrobial Chemother 22:631-636, 1988
20. Bazzoli F, Zagari RM, Fossi S, Pozzato P, Alampi G, Simoni P, et al: Short-term, low-dose triple therapy for the eradication of Helicobacter pylori. Eur J Gastroenterol Hepatol 6:773-777, 1994
21. Lind T, Veldhuyzen van Zanten SJO, Huge P, Spiller RC, Bayerdorfller E, O'Morain C, Bardhan KD, Bradette M, Chiba N, Wrangstadh M, Cederberg C, Idstrom J-P: Eradication of Helicobacter pylori using one-week triple therapies combining omeprazole with two antimicrobials: The MACH l Study. Helicobacter 1:138-144, 1996
22. Xia HX, Daw MA, Sant S, Beattie S, Keane (T. O'Morain CA: Clinical efficacy of triple therapy in Helicobacter pylori associated duodenal ulcer. Eur J Gastroenterol Hepatol 5:141-144, 1993
23. Xia HX, Daw MA, Keane CT. O'Morain CA: The prevalence of metronidazole-resistant Helicobacter plori in Irish dyspeptic patients. Ir J Med Sci 162:91-94, 1993
24. Xia HX, Keane CT, Beattie S, O'Morain CA. Standardisation of disc diffusion test and its clinical significance for susceptibility testing of metronidazole against Helicobacter pylori. Antimicrob Agents Chemother 38:2357-2361, 1994
25. Xia HX, Buckley M, Keane CT, O'Morain CA: Clarithromycin resistance in Helicobacter pylori: Prevalence in untreated dyspeptic patients and stability in vitro. J Antimicrob Chemother 37:473-481, 1996
26. Unge P, Berstad A: Pooled analysis of anti-Helicobacter pylori treatment regimens. Scand J Gastroenterol 31(suppl 220):27-40, 1996
27. European Study Group on Antibiotic Susceptibility of Helicobacter pylori: Results of a multicentre European Survey in 1991 of metronidazole resistance in Helicobacter pylori. Eur J Clin Microbiol Infect Dis 11:777-781, 1992
28. Becx MCJM, Janssen AJHM, Clasener HAL, de Koning RW: Metronidazole-resistant Helicobacter pylori. Lancet 335:539-540, 1990
29. Glupczynski Y, Burette A, de Koster E, Nyst JF, Deltenre M, Cadranel S, Bourdeaux L, de Vos D: Metronidazole resistance in Helicobacter pylori. Lancet 335:976-977, 1990
30. Rautelin H, Seppala K, Renkonen O-V, Vainio U, Kosunen TU: Role of metronidazole resistance in therapy of Helicobacter pylori. infections. Antimicrob Agents Chemother 36:163-166, 1992
31. van Zwet AA, Thijs JC, Oom JAJ, Hoogeveen J, Duringshoff BL. Failure to eradicate Helicobacter in patients with metronidazole-resistant strains. Eur J Gastroenterol Hepatol 5:185-186, 1993
32. van Zwet AA, Thijs, de Vries WS, Schiphius J, Snijder JAM: In vitro studies on stability and development of metronidazole resistance in Helicobacter pylori. Antimicrob Agents Chemother 38:360-362, 1994
33. Banatvala N, Davies GR, Abdi Y, Clements L, Rampton DS, Hardie JM, Feldman RA: High prevalence of Helicobacter pylori. metronidazole resistance in migrants to east London: Relation with previous nitroimodazole exposure and gastroduodenal disease. Gut 35:1562-1566, 1994
34. Weisblum B: Erythromycin resistance by ribosomal modification. Antimicrob Agents and Chemother 39:577-585, 1995
35. Versalovic J, Kibler K, Small S, Graham DY, Go MF: Mutations in the 23S ribosomal RNA confer clarithromycin resistance in Helicobacter pylori. Gut 37(suppl 1):A67, 1995
36. Hultén K, Engstrand L: Acquired and persistent macrolide resistance in patients treated with clarithromycin. Gut 39(suppl 2):A8, 1996
37. Moayyedi P, Sahay P, Tompkins DS, Axon ATR: Efficacy and optimum dose of omeprazole in a new one-week triple therapy regimen to eradicate Helicobacter pylori. Eur J Gastroenterol Hepatol 7:835-840, 1995
38. Yousfi MM, El-Zimaity HMT, AI-Assi MT, Cole RA, Genta RM, Graham DY: Metronidazole, omeprazole and clarithromycin: An effective combination therapy for Helicobacter pylori infection. Aliment Pharmacol Ther 9:209-212, 1995
39. de Boer W, Driessen W, Jansz A, Tytgat G: Effect of acid suppression on efficacy of treatment for Heticobacter pylori. Lancet 345:817-820, 1995
40. Cayla R, Zerbib F, de Mascare F, Megraud F, Lamouliatte H: Dual therapy with high dose of omeprazole versus triple therapy using omeprazole in combination with two antibiotics for H. pylori cradication. Am J Gastroenterol 89:1366, 1994 (abstract)
41. Tham TCK, Collins JSA, McCormick C, Sloan JM, Bamford K, Watson RGP: Randomised controlled trial of ranitidine and omeprazole and their combination with antibiotics in the eradication of Helicobacter pylori. Gastroenterology 108:A240, 1995 (abstract)
42. Bell GD, Powell KU, Burridge SM, Bowden AF, Atoyebi W, Bolton GH, Jones PH, Brown C: Rapid eradication of Helicobacter pylori infection. Aliment Pharmacol Ther 9:41-46, 1995
43. Lamouliatte H, Cayla R, Zerbib F, Megraud F: Triple therapy with proton pump inhibitor, amoxicillin and clarithromycin for Helicobacter pylori eradication. Gastroenterology 108:A143, 1995 (abstract)
44. Harris A, Misiewicz JJ: Hitting H, pylori for four. Lancet 345:806-807, 1995 (commentary)
45. Vautier G, Scott BB: A one-week quadruple eradication regimen for Helicobacter pylori in routine clinical practice. Aliment Pharmacol Ther 11:107-108, 1997
46. Malfertheiner P, Megraud F, O'Morain C, Bell D, Porro GB, Deltenre M, Forman D, et al: Current European concepts in the management of H. pylori infection-The Maastricht Consensus Report. Eur J Gastroenterol Hepatol 9:1-2, 1997